ALB and hepatocellular carcinoma: The albumin-to-alkaline phosphatase ratio (AAPR), which is obtained by dividing the serum albumin level by that of serum alkaline phosphatase, was first examined in patients with hepatocellular carcinoma in 2015 [17].